Display options
Share it on

J Clin Transl Hepatol. 2016 Mar 28;4(1):54-65. doi: 10.14218/JCTH.2015.00041. Epub 2016 Mar 15.

Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation.

Journal of clinical and translational hepatology

Rakhi Maiwall, Manoj Kumar

Affiliations

  1. Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, New Delhi, India.

PMID: 27047773 PMCID: PMC4807144 DOI: 10.14218/JCTH.2015.00041

Abstract

Chronic hepatitis B is a global health problem that leads to development of various complications, such as cirrhosis, liver cancer, and liver failure requiring liver transplantation. The recurrence of hepatitis B virus (HBV) post-liver transplantation is a major cause of allograft dysfunction, cirrhosis of the allograft, and graft failure. Patients with high viral load at the time of transplantation, hepatitis B e antigen (HBeAg) positivity, or those with a history of anti-viral drug resistance are considered as high-risk for recurrent HBV post-liver transplantation, while patients with low viral load, including HBeAg negative status, acute liver failure, and hepatitis D virus (HDV) co-infection are considered to be at low-risk for recurrent HBV post-liver transplantation. Antivirals for patients awaiting liver transplantation(LT) cause suppression of HBV replication and reduce the risk of recurrent HBV infection of the allograft and, therefore, all HBV patients with decompensated cirrhosis should be treated with potent antivirals with high genetic barrier to resistance (entecavir or tenofovir) prior to liver transplantation. Prevention of post-liver transplantation recurrence should be done using a combination of hepatitis B immunoglobulin (HBIG) and antivirals in patients at high risk of recurrence. Low dose HBIG, HBIG-free protocols, and monoprophylaxis with high potency antivirals can still be considered in patients at low risk of recurrence. Even, marginal grafts from anti-HBc positive donors can be safely used in hepatitis B surface antigen (HBsAg) negative, preferably in anti-hepatitis B core (HBc)/anti-hepatitis B surface (HBs) positive recipients. In this article, we aim to review the mechanisms and risk factors of HBV recurrence post-LT in addition to the various treatment strategies proposed for the prevention of recurrent HBV infection.

Keywords: Hepatitis B; Liver transplant; Recurrent

References

  1. J Hepatol. 2001 Jun;34(6):903-10 - PubMed
  2. Virus Res. 2007 Jun;126(1-2):245-9 - PubMed
  3. Liver Transpl. 2006 Feb;12 (2):253-8 - PubMed
  4. Gastroenterology. 2011 Oct;141(4):1212-9 - PubMed
  5. Hepatology. 1996 Dec;24(6):1327-33 - PubMed
  6. J Hepatol. 2003 Jun;38(6):811-7 - PubMed
  7. J Hepatol. 1999 Apr;30(4):715-21 - PubMed
  8. Int J Inflam. 2014;2014:814760 - PubMed
  9. Gastroenterology. 2005 Jul;129(1):234-45 - PubMed
  10. Antivir Ther. 2011;16(4):479-87 - PubMed
  11. Hepatology. 2003 Oct;38(4):811-9 - PubMed
  12. J Hepatol. 2010 Feb;52(2):272-9 - PubMed
  13. Int J Mol Sci. 2015 Jul 30;16(8):17494-513 - PubMed
  14. Hepatology. 2002 Jun;35(6):1528-35 - PubMed
  15. J Biol Chem. 2015 Feb 27;290(9):5673-84 - PubMed
  16. Am J Pathol. 1986 Oct;125(1):161-72 - PubMed
  17. Dig Dis Sci. 2010 Feb;55(2):505-9 - PubMed
  18. Transplantation. 2009 Jan 15;87(1):103-11 - PubMed
  19. J Med Virol. 2013 Nov;85(11):1900-6 - PubMed
  20. Nat Med. 1996 Oct;2(10):1104-8 - PubMed
  21. Clin Transplant. 2011 Jul-Aug;25(4):517-22 - PubMed
  22. Transpl Infect Dis. 2015 Jun;17(3):329-33 - PubMed
  23. Gastroenterology. 1999 Dec;117(6):1386-96 - PubMed
  24. Liver Transpl. 2007 Mar;13(3):367-73 - PubMed
  25. Liver. 1999 Jun;19(3):177-82 - PubMed
  26. Liver Transpl. 2013 Jun;19(6):594-601 - PubMed
  27. Hepatology. 2000 Feb;31(2):496-501 - PubMed
  28. J Hepatol. 2012 May;56(5):1189-97 - PubMed
  29. J Virol. 2003 Aug;77(16):8882-92 - PubMed
  30. PLoS One. 2013;8(3):e59611 - PubMed
  31. EMBO J. 2007 Sep 19;26(18):4160-7 - PubMed
  32. Elife. 2012 Nov 13;1:e00049 - PubMed
  33. Gut. 2010 Oct;59(10):1430-45 - PubMed
  34. Gastroenterology. 2013 Jun;144(7):1508-17, 1517.e1-10 - PubMed
  35. Gastroenterology. 2007 Mar;132(3):931-7 - PubMed
  36. Am J Gastroenterol. 2013 Jun;108(6):942-8 - PubMed
  37. Gastroenterology. 2010 Feb;138(2):682-93, 693.e1-4 - PubMed
  38. Transplant Proc. 2002 Jun;34(4):1252-4 - PubMed
  39. Hepatol Int. 2016 Jan;10 (1):1-98 - PubMed
  40. Hepatology. 2008 Nov;48(5):1460-6 - PubMed
  41. Hepatology. 2000 Dec;32(6):1189-95 - PubMed
  42. Hepatol Int. 2011 Mar 25;5(4):918-926 - PubMed
  43. Intervirology. 2014;57(3-4):196-201 - PubMed
  44. Am J Transplant. 2013 Feb;13(2):353-62 - PubMed
  45. Liver Transpl. 2000 Nov;6(6):741-8 - PubMed
  46. Gastroenterology. 1988 Jan;94(1):151-6 - PubMed
  47. Liver Transpl. 2007 Mar;13(3):349-60 - PubMed
  48. Transpl Int. 2010 Nov;23(11):1105-12 - PubMed
  49. Transpl Infect Dis. 2012 Oct;14 (5):479-87 - PubMed
  50. J Hepatol. 2011 Sep;55(3):587-93 - PubMed
  51. Transplantation. 1996 May 15;61(9):1358-64 - PubMed
  52. Antimicrob Agents Chemother. 2012 Aug;56(8):4277-88 - PubMed
  53. Cochrane Database Syst Rev. 2010 Jul 07;(7):CD006005 - PubMed
  54. Transplant Proc. 2001 Nov-Dec;33(7-8):3637-8 - PubMed
  55. Gastroenterology. 1993 Jun;104(6):1818-21 - PubMed
  56. Ann Surg. 2001 Feb;233(2):276-81 - PubMed
  57. Mol Ther. 2013 May;21(5):973-85 - PubMed
  58. J Viral Hepat. 2005 Mar;12(2):212-5 - PubMed
  59. J Hepatol. 1999 Apr;30(4):706-14 - PubMed
  60. J Hepatol. 2009 Sep;51(3):581-92 - PubMed
  61. Hepatology. 2003 Jul;38(1):86-95 - PubMed
  62. Am J Transplant. 2011 Mar;11(3):511-7 - PubMed
  63. Liver Transpl. 2007 Mar;13(3):374-81 - PubMed
  64. Dig Dis Sci. 2007 Oct;52(10 ):2497-500 - PubMed
  65. Am J Transplant. 2010 Aug;10 (8):1823-33 - PubMed
  66. Hepatology. 2002 Jan;35(1):176-81 - PubMed
  67. J Med Virol. 1997 Jun;52(2):226-33 - PubMed
  68. Transplant Proc. 2004 Apr;36(3):535-8 - PubMed
  69. Nat Biotechnol. 2008 Mar;26(3):335-41 - PubMed
  70. Liver Transpl. 2006 Feb;12(2):316-9 - PubMed
  71. N Engl J Med. 1993 Dec 16;329(25):1842-7 - PubMed
  72. Liver Transpl. 2011 Oct;17 (10 ):1176-90 - PubMed
  73. Acta Med Okayama. 2014;68(1):53-6 - PubMed
  74. Liver Transpl. 2007 Jan;13(1):71-9 - PubMed
  75. Gastroenterology. 2014 Jul;147(1):48-64 - PubMed
  76. Transplantation. 2001 Oct 27;72 (8):1381-5 - PubMed
  77. Am J Transplant. 2013 Feb;13(2):348-52 - PubMed
  78. J Hepatol. 2013 May;58(5):861-7 - PubMed
  79. J Hepatol. 2014 Apr;60(4):723-31 - PubMed
  80. Liver Transpl. 2005 Apr;11(4):402-9 - PubMed
  81. J Viral Hepat. 2010 Feb 1;17(2):123-9 - PubMed
  82. Liver Transpl. 2013 Mar;19(3):268-74 - PubMed
  83. Clin Transplant. 2006 Mar-Apr;20(2):206-10 - PubMed
  84. Front Immunol. 2014 Jun 03;5:258 - PubMed
  85. Hepatology. 1998 Aug;28(2):585-9 - PubMed
  86. Hepatology. 2011 May;53(5):1494-503 - PubMed
  87. Transplantation. 1998 Feb 27;65(4):494-9 - PubMed
  88. Am J Pathol. 1990 Sep;137(3):667-76 - PubMed
  89. Hepatology. 1991 Apr;13(4):619-26 - PubMed
  90. J Gastroenterol. 2013 Dec;48(12 ):1401-10 - PubMed
  91. Transpl Int. 2009 Apr;22(4):387-94 - PubMed
  92. PLoS One. 2012;7(10 ):e47648 - PubMed
  93. Liver Transpl. 2013 Sep;19(9):1030-5 - PubMed
  94. Hepatology. 2001 Feb;33(2):424-32 - PubMed
  95. Liver Transpl. 2005 Oct;11(10 ):1228-34 - PubMed
  96. World J Gastroenterol. 2013 Dec 28;19(48):9189-97 - PubMed
  97. J Hepatol. 2001 Jun;34(6):895-902 - PubMed
  98. Gastroenterology. 2008 Jun;134(7):1890-9; quiz 2155 - PubMed
  99. J Infect Dis. 1999 Jul;180(1):15-26 - PubMed
  100. World J Gastroenterol. 2007 Jan 7;13(1):65-73 - PubMed
  101. Transplant Proc. 2006 Mar;38(2):579-83 - PubMed
  102. Transpl Infect Dis. 2015 Apr;17 (2):208-20 - PubMed
  103. J Virol. 2007 Apr;81(8):4215-25 - PubMed
  104. Transplantation. 2007 Sep 15;84(5):650-4 - PubMed

Publication Types